Clinical Trial_Page_4_Providing professional financial news and data related to Clinical Trial, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

SINO BIOPHARM(01177.HK): Class 1 Innovative Drug Pelecanam Spray (Puyike®) Approved by NMPA for Secondary Wound Infection Caused by Burns and Scalds

Tags：

SINO BIOPHARM 01177.HK Clinical Trial

2026-06-23

SIHUAN PHARM(00460.HK): First Patient Dosed in Phase III Trial of Anaprazole Sodium from Xuanzhu Biologics for Helicobacter Pylori Eradication

Tags：

SIHUAN PHARM 00460.HK Clinical Trial

2026-06-22

INNOGEN-B(02591.HK): Ib-stage Clinical Trial of Efsubaglutide Alfa for Adolescent Obesity Approved, Expected to Kick Off in July

Tags：

INNOGEN-B 02591.HK Clinical Trial

2026-06-22

Henlius(02696.HK):Phase 2 Clinical Trial of HLX43 Combined with Serplulimab for Neoadjuvant Treatment of NSCLC Approved in Australia

Tags：

HENLIUS 02696.HK HLX43 Clinical Trial

2026-06-16

HENLIUS(02696.HK): HLX04-O Meets Primary Endpoint in Global Multicenter Phase 3 Trial for Wet Age-Related Macular Degeneration

Tags：

HENLIUS 02696.HK Clinical Trial

2026-06-16

LongBio Pharma-B(01779.HK): LP-003 Phase III Trial for Seasonal Allergic Rhinitis Hits Primary Endpoint

Tags：

LongBio Pharma-B 01779.HK Clinical Trial

2026-06-12

UNITED LAB(03933.HK): TUL321 Capsule Granted Implied Approval for Clinical Trials of New Drug in China

Tags：

UNITED LAB 03933.HK Clinical Trial

2026-06-11

CSPC PHARMA(01093.HK): Phase III Study of Anistolimab Combined with HB1801 for HER2-positive Advanced Breast Cancer Meets Primary Endpoint

Tags：

CSPC PHARMA 01093.HK Clinical Trial

2026-06-10

HBM HOLDINGS-B (02142.HK): NMPA Accepts IND Application of HBM7004 for Advanced Solid Tumors

Tags：

HBM HOLDINGS-B 02142.HK Clinical Trial

2026-06-10

Leads Biolabs-B (09887.HK): Core Bispecific Antibody Initiates Phase Ib/II Trial for Triple-Negative Breast Cancer

Tags：

LEADS BIOLABS-B 09887.HK Clinical Trial

2026-02-10

Scan QR Code

Download App